Compound ID | 75
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Natural product; Direct acting; Bacteriophage or bacteriphage-derived product; |
| Target Pathogen: | Active against beta-haemolytic Streptococcus agalactiae |
| Institute where first reported: | Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland |
| Year first mentioned: | 2013 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|